118 related articles for article (PubMed ID: 9354616)
1. Catalytic domain structure of vampire bat plasminogen activator: a molecular paradigm for proteolysis without activation cleavage.
Renatus M; Stubbs MT; Huber R; Bringmann P; Donner P; Schleuning WD; Bode W
Biochemistry; 1997 Nov; 36(44):13483-93. PubMed ID: 9354616
[TBL] [Abstract][Full Text] [Related]
2. The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator.
Lamba D; Bauer M; Huber R; Fischer S; Rudolph R; Kohnert U; Bode W
J Mol Biol; 1996 Apr; 258(1):117-35. PubMed ID: 8613982
[TBL] [Abstract][Full Text] [Related]
3. Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA.
Renatus M; Engh RA; Stubbs MT; Huber R; Fischer S; Kohnert U; Bode W
EMBO J; 1997 Aug; 16(16):4797-805. PubMed ID: 9305622
[TBL] [Abstract][Full Text] [Related]
4. Structural features mediating fibrin selectivity of vampire bat plasminogen activators.
Bringmann P; Gruber D; Liese A; Toschi L; Krätzchmar J; Schleuning WD; Donner P
J Biol Chem; 1995 Oct; 270(43):25596-603. PubMed ID: 7592732
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride.
Jankun J; Skrzypczak-Jankun E
Cancer Biochem Biophys; 1999 Jul; 17(1-2):109-23. PubMed ID: 10738907
[TBL] [Abstract][Full Text] [Related]
6. [Construction of Pichia pastoris strain expressing salivary plasminogen activator from vampire bat (Desmodus rotundus)].
Liu Y; Su C; Song X; Tang Y; Bao Z
Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):566-74. PubMed ID: 19637633
[TBL] [Abstract][Full Text] [Related]
7. Function of the central domain of streptokinase in substrate plasminogen docking and processing revealed by site-directed mutagenesis.
Chaudhary A; Vasudha S; Rajagopal K; Komath SS; Garg N; Yadav M; Mande SC; Sahni G
Protein Sci; 1999 Dec; 8(12):2791-805. PubMed ID: 10631997
[TBL] [Abstract][Full Text] [Related]
8. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
[TBL] [Abstract][Full Text] [Related]
9. Mutagenesis at Pro309 of single-chain urokinase-type plasminogen activator alters its catalytic properties.
Sun Z; Liu JN
Proteins; 2005 Dec; 61(4):870-7. PubMed ID: 16231330
[TBL] [Abstract][Full Text] [Related]
10. Functional roles of streptokinase C-terminal flexible peptide in active site formation and substrate recognition in plasminogen activation.
Zhai P; Wakeham N; Loy JA; Zhang XC
Biochemistry; 2003 Jan; 42(1):114-20. PubMed ID: 12515545
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.
Anglés-Cano E; Rojas G
Biol Chem; 2002 Jan; 383(1):93-9. PubMed ID: 11928826
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory mechanism of serpins: loop insertion forces acylation of plasminogen activator by plasminogen activator inhibitor-1.
Kvassman JO; Verhamme I; Shore JD
Biochemistry; 1998 Nov; 37(44):15491-502. PubMed ID: 9799512
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).
Kemball-Cook G; Johnson DJ; Tuddenham EG; Harlos K
J Struct Biol; 1999 Oct; 127(3):213-23. PubMed ID: 10544046
[TBL] [Abstract][Full Text] [Related]
14. Model for substrate interactions in C5a peptidase from Streptococcus pyogenes: A 1.9 A crystal structure of the active form of ScpA.
Kagawa TF; O'Connell MR; Mouat P; Paoli M; O'Toole PW; Cooney JC
J Mol Biol; 2009 Feb; 386(3):754-72. PubMed ID: 19152799
[TBL] [Abstract][Full Text] [Related]
15. The structure of truncated recombinant human bile salt-stimulated lipase reveals bile salt-independent conformational flexibility at the active-site loop and provides insights into heparin binding.
Moore SA; Kingston RL; Loomes KM; Hernell O; Bläckberg L; Baker HM; Baker EN
J Mol Biol; 2001 Sep; 312(3):511-23. PubMed ID: 11563913
[TBL] [Abstract][Full Text] [Related]
16. Fibrin selectivity of the isolated protease domains of tissue-type and vampire bat salivary gland plasminogen activators.
Toschi L; Bringmann P; Petri T; Donner P; Schleuning WD
Eur J Biochem; 1998 Feb; 252(1):108-12. PubMed ID: 9523718
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activators from the saliva of Desmodus rotundus (common vampire bat): unique fibrin specificity.
Schleuning WD; Alagon A; Boidol W; Bringmann P; Petri T; Krätzschmar J; Haendler B; Langer G; Baldus B; Witt W
Ann N Y Acad Sci; 1992 Dec; 667():395-403. PubMed ID: 1309059
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional basis of plasminogen activation by staphylokinase.
Jespers L; Vanwetswinkel S; Lijnen HR; Van Herzeele N; Van Hoef B; Demarsin E; Collen D; De Maeyer M
Thromb Haemost; 1999 Apr; 81(4):479-85. PubMed ID: 10235424
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the human carboxypeptidase N (kininase I) catalytic domain.
Keil C; Maskos K; Than M; Hoopes JT; Huber R; Tan F; Deddish PA; Erdös EG; Skidgel RA; Bode W
J Mol Biol; 2007 Feb; 366(2):504-16. PubMed ID: 17157876
[TBL] [Abstract][Full Text] [Related]
20. Structure of human pro-chymase: a model for the activating transition of granule-associated proteases.
Reiling KK; Krucinski J; Miercke LJ; Raymond WW; Caughey GH; Stroud RM
Biochemistry; 2003 Mar; 42(9):2616-24. PubMed ID: 12614156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
